These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29966535)

  • 81. Population biology of human onchocerciasis.
    Basáñez MG; Boussinesq M
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Interruption of the transmission of Onchocerca volvulus in the Kashoya-Kitomi focus, western Uganda by long-term ivermectin treatment and elimination of the vector Simulium neavei by larviciding.
    Lakwo T; Garms R; Wamani J; Tukahebwa EM; Byamukama E; Onapa AW; Tukesiga E; Katamanywa J; Begumisa S; Habomugisha P; Oguttu D; Byamukama E; Richards F; Unnasch TR; Katabarwa M
    Acta Trop; 2017 Mar; 167():128-136. PubMed ID: 28034767
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Control of onchocerciasis today: status and challenges.
    Richards FO; Boatin B; Sauerbrey M; Sékétéli A
    Trends Parasitol; 2001 Dec; 17(12):558-63. PubMed ID: 11756018
    [No Abstract]   [Full Text] [Related]  

  • 84. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Refocusing vector assessment towards the elimination of onchocerciasis from Africa: a review of the current status in selected countries.
    Boakye D; Tallant J; Adjami A; Moussa S; Tekle A; Robalo M; Rebollo M; Mwinza P; Sitima L; Cantey P; Mackenzie C
    Int Health; 2018 Mar; 10(suppl_1):i27-i32. PubMed ID: 29471346
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
    Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
    Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.
    Katabarwa MN; Zarroug IMA; Negussu N; Aziz NM; Tadesse Z; Elmubark WA; Shumo Z; Meribo K; Kamal H; Mohammed A; Bitew Y; Seid T; Bekele F; Yilak A; Endeshaw T; Hassen M; Tillahun A; Samuel F; Birhanu H; Asmare T; Boakye D; Feleke SM; Unnasch T; Post R; Higazi T; Griswold E; Mackenzie C; Richards F
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007830. PubMed ID: 32027648
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions.
    Colebunders R; Stolk WA; Siewe Fodjo JN; Mackenzie CD; Hopkins A
    Infect Dis Poverty; 2019 Oct; 8(1):83. PubMed ID: 31578157
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [The use of ivermectin in the control of onchocerciasis].
    Chippaux JP; Boussinesq M; Prod'hon J
    Sante; 1995; 5(3):149-58. PubMed ID: 7640897
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.
    Hoerauf A; Mand S; Adjei O; Fleischer B; Büttner DW
    Lancet; 2001 May; 357(9266):1415-6. PubMed ID: 11356444
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
    Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
    Wilson NO; Badara Ly A; Cama VA; Cantey PT; Cohn D; Diawara L; Direny A; Fall M; Feeser KR; Fox LM; Kabore A; Seck AF; Sy N; Ndiaye D; Dubray C
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005198. PubMed ID: 27926918
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
    Eisenbarth A; Achukwi MD; Renz A
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004392. PubMed ID: 26926855
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Alternative treatment strategies to accelerate the elimination of onchocerciasis.
    Boussinesq M; Fobi G; Kuesel AC
    Int Health; 2018 Mar; 10(suppl_1):i40-i48. PubMed ID: 29471342
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: elimination of transmission in the north-east focus of the Bolivarian Republic of Venezuela.
    Wkly Epidemiol Rec; 2017 Oct; 92(41):617-23. PubMed ID: 29028167
    [No Abstract]   [Full Text] [Related]  

  • 97. Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.
    Walker M; Pion SDS; Fang H; Gardon J; Kamgno J; Basáñez MG; Boussinesq M
    Clin Infect Dis; 2017 Nov; 65(12):2026-2034. PubMed ID: 29020189
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).
    Noma M; Nwoke BE; Nutall I; Tambala PA; Enyong P; Namsenmo A; Remme J; Amazigo UV; Kale OO; Sékétéli A
    Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S29-39. PubMed ID: 12081248
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Imaramagambo Onchocerciasis Focus in Southwestern Uganda: Interruption of Transmission After Disappearance of the Vector Simulium neavei and Its Associated Freshwater Crabs.
    Katabarwa MN; Katamanywa J; Lakwo T; Habomugisha P; Byamukama E; Oguttu D; Nahabwe C; Ngabirano M; Tukesiga E; Khainza A; Tukahebwa E; Unnasch TR; Richards FO; Garms R
    Am J Trop Med Hyg; 2016 Aug; 95(2):417-425. PubMed ID: 27215297
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Use of Ov16-Based Serology for Post-Elimination Surveillance of Onchocerciasis in Ecuador.
    Guevara Á; Salazar E; Vicuña Y; Hassan HK; Muro A; Guderian R; Cooper PJ; Unnasch TR
    Am J Trop Med Hyg; 2020 Oct; 103(4):1569-1571. PubMed ID: 32840200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.